Used in Suzuki-Miyaura cross-coupling reactions to introduce the (1R,2S)-2-methylcyclopropyl group into organic molecules, enabling the synthesis of chiral cyclopropane-containing compounds. These structures are valuable in pharmaceutical development due to their metabolic stability and conformational rigidity. The boronic acid serves as a key building block for creating bioactive molecules, particularly in the design of drugs targeting central nervous system disorders and antiviral agents. Its stereospecific structure allows for precise control over molecular geometry in synthetic pathways.